The latest announcement is out from Biophytis ( (BPTSY) ).
On March 28, 2025, Biophytis S.A. announced the successful settlement and delivery of a €2.6 million private placement, involving the issuance of new ordinary shares and prepaid subscription warrants. This financial move, facilitated by Maxim Group LLC and Invest Securities, is expected to enhance Biophytis’s market position by increasing liquidity and potentially expanding its shareholder base. The new shares and warrants have been listed on Euronext Growth, reflecting the company’s strategic efforts to strengthen its capital structure and support its ongoing development initiatives.
More about Biophytis
Biophytis S.A. is a clinical-stage biotechnology company focused on developing treatments for age-related diseases. The company operates in the biotechnology industry and is known for its innovative approach to addressing health issues associated with aging.
YTD Price Performance: -47.36%
Average Trading Volume: 3
Technical Sentiment Signal: Buy
Current Market Cap: $4.3M
Learn more about BPTSY stock on TipRanks’ Stock Analysis page.